APA (7th ed.) Citation

JJ, O., S, K., DB, R., CL, P., P, C., A, R. G., . . . RC, F. (2018). The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus. Arthritis research & therapy, 20(1), 152. https://doi.org/10.1186/s13075-018-1649-1

Chicago Style (17th ed.) Citation

JJ, Oliveira, et al. "The Plasma Biomarker Soluble SIGLEC-1 Is Associated with the Type I Interferon Transcriptional Signature, Ethnic Background and Renal Disease in Systemic Lupus Erythematosus." Arthritis Research & Therapy 20, no. 1 (2018): 152. https://doi.org/10.1186/s13075-018-1649-1.

MLA (9th ed.) Citation

JJ, Oliveira, et al. "The Plasma Biomarker Soluble SIGLEC-1 Is Associated with the Type I Interferon Transcriptional Signature, Ethnic Background and Renal Disease in Systemic Lupus Erythematosus." Arthritis Research & Therapy, vol. 20, no. 1, 2018, p. 152, https://doi.org/10.1186/s13075-018-1649-1.